¿Pueden las farmacéuticas chinas desarrollar fármacos innovadores contra el cáncer? 🇨🇳💊

3 terapias de BeiGene:
💊 Zanubrutinib
💉 Tislelizumab
🧬 Pamiparib

🎥 Mira el video para conocer más.

#BeiGene #ChinesePharma #CancerTherapy #Oncology #DengYueMed

MSD, AZ partner LaNova bought by Sino Biopharm for $951m LaNova Medicines is being bought out by minority shareholder Sino Biopharm in a deal valued at around $951 million

In a case of consolidation in the #Chinesepharma sector, #LaNovaMedicines is being bought out by minority shareholder #SinoBiopharm in a deal valued at around $951 million.

pharmaphorum.com/news/msd-az-...